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Jesus E. Perez Torga4 and Pedro A. Roman Rubio4
Abstract
Objective: To inform on delivery outcomes achieved in congenital heart disease (CHD) patients by the Cuban
National Programme for pregnancy and heart disease.
Methods: Single-centre retrospective study on a prospectively collected cardiac pregnancy database at a tertiary
referral hospital (January 2000–May 2017). Primary outcomes: pregnancy duration, outcome, maternal/fetal
complications.
Results: Four hundred sixty-seven pregnancies in 462 recorded cases reached third trimester. Median age: 25 (21–29)
years. Patients presented in NYHA class I (97%, n = 453) or II (3%, n = 14), 6% (n = 27) had arrhythmias, 1% (n = 4) had
co-morbidities, 1% (n = 4) had impaired left ventricular function. There were 464 singleton pregnancies and 3 twin
pregnancies. Of the singleton pregnancies, one resulted in stillbirth (0.2%). The rest were live births (n = 463), median
weight 3200 (2900–3421) grams. Median pregnancy duration: 39.1 (38.6–40) weeks. Caesarean rate: 34% (n = 156). All
twin pregnancies (n = 3) resulted in live births (n = 6) via caesarean section, of median weight 2710 (2458–2850) grams
and median pregnancy duration 37 (36–38) weeks. Maternal cardiovascular complications (< 0.5%, n = 2), and obstetric
complications (14%, n = 67) did not result in any mortality. Small-for-gestational-age was the commonest neonatal
complication (10%, n = 48), with zero mortality. Three neonates (1%) had CHD. Post-delivery maternal NYHA functional
status: class I in 84% (n = 393), class II in 16% (n = 73), and class III in one patient (< 0.5%).
Conclusion: In middle-income countries management of CHD pregnancies according to existing guidelines can
achieve good maternal and fetal outcomes.
Keywords: Congenital heart disease, Pregnancy, Delivery outcomes, Cuba
Introduction
Due to developments in cardiac surgery and congenital
cardiology, women with congenital heart disease (CHD)
are now consistently reaching adulthood [1]. CHD has
since become one of the most common types of heart
disease in pregnancy [2], and represents a significant
cause of morbidity to the gravid patient, as well as a risk
of mortality [3, 4]. In the developed world, high-risk
pregnant CHD patients should have access to tertiary
Adult Congenital Heart Disease (ACHD) centres [5, 6].
Conversely, little is known about pregnancy outcomes
for women in low and middle-income countries [3]. This
article seeks to address this gap in the literature, examin-
ing and updating the delivery outcomes achieved in
CHD patients managed by the Cuban National
Programme for pregnancy and heart disease [7, 8].
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Complications in CHD pregnancies and risk assessment
Complications arising from a CHD pregnancy can be
broadly divided into three main categories: maternal
cardiac complications, obstetric complications and fetal
complications. Studies have estimated the incidence of
cardiac complications at 10–13% in the CHD population
[9–11]. Amongst these, heart failure and arrhythmias
were identified as the most common [12]. In terms of
obstetric complications, CHD pregnancies are associated
with a higher rate of thromboembolism than in the gen-
eral population (1:50 vs 1:1000-2000) [11]. Whilst overall
rates of pregnancy-related hypertensive disorders are
broadly similar to that of the healthy population (8.7% vs
8%), the incidence of pre-eclampsia and pregnancy
induced hypertension can vary widely depending on the
specific CHD examined. Lastly, it is estimated that 30%
of fetuses experience complications [13], and women
with CHD are more likely to have a spontaneous miscar-
riage or therapeutic abortion [14]. Further complications
include an increased risk of premature birth above back-
ground, growth restriction and stillbirth [4, 9, 15–17],
perhaps going some way in explaining why fetal mortal-
ity rates are four times higher in CHD pregnancies [13].
Overall, maternal mortality is not particularly high for
most types of CHD, however rates of morbidity remain
much higher in CHD patients and their offspring than in
the general population [2].
Because of the high risk of complications in pregnancy
and delivery, the importance of preconception counsel-
ling and appropriate risk stratification cannot be over-
stated. Preconception counselling should begin in
adolescence, and should take place in a tertiary centre
experienced in both the care of ACHD patients and
high-risk pregnancies. Advice provided varies on a
case-by-case basis, but should generally include guidance
on appropriate contraception methods, a medication
review and an appropriate assessment of the maternal
cardiovascular risk that would be sustained in pregnancy
[5, 6]. Three risk calculators have been validated to pro-
vide reliable information in this regard: the modified
World Health Organisation (mWHO) classification of
pregnancy risk [18], the CARPREG risk score [9] and
the ZAHARA risk score [4]. Of these, the most effective
is the mWHO classification of pregnancy risk, which is
based primarily on the type and severity of the maternal
heart defect [10].
The management of delivery in CHD patients
Guidelines on the management of delivery in CHD preg-
nancies have become more widely available in recent
years. Pregnant women considered high-risk (mWHO
class III-IV) should always give birth in a tertiary care
centre where an appropriate multi-disciplinary team
(MDT) can be called upon [5, 6]. Members of the MDT
will usually include an experienced obstetrician, a cardi-
ologist, a neonatologist and an anaesthetist [19]. Spontan-
eous vaginal delivery is considered the preferred option
for most CHD patients. Exceptions to this include an
obstetric indication and/or a small number of high-risk
cardiac conditions, where the Valsalva manoeuvre during
active second stage may cause potentially detrimental
haemodynamic changes [6, 19]. Indications for caesarean
section (CS) include patients on oral anticoagulants going
into preterm labour, Marfan’s syndrome and other aorto-
pathies with a fragile aorta, and the presence of acute
intractable heart failure [6]. However, most guidance in
this regard lacks definitive evidence, and relies instead on
expert opinion.
Managing CHD pregnancies in low and middle-income
countries
CHD expertise can be much more difficult to access in
low and middle-income countries. In Latin America,
exceptions to this rule are found in Mexico, Brazil and
Cuba, where contrary to the norm, such care is available
to the population [20–22]. The Cuban National
Programme for heart disease in pregnancy remains the
most established of these, having been in existence for
close to 20 years.
It operates under the umbrella of the Institute of Cardi-
ology and Cardiovascular Surgery in Havana, and has its
base at the Hospital of Obstetrics and Gynaecology “Ramon
Gonzalez Coro”, also based in Havana. As a national
service, patients are referred via regional coordinators, and
are assessed by the team of two consultant cardiologists
and an obstetrician working for the Programme. Those
deemed of sufficiently high-risk (mWHO criteria class
II-III, III and IV) [18] are managed by the team for the dur-
ation of their pregnancy. Patients with pregnancies deemed
class I and II are referred back to their regional hospital,
with remote support available from the team where neces-
sary. Pregnancies managed by the team in Havana are
reviewed at 20–22 weeks, at 28–29weeks, 34 weeks and at
term. A cardiovascular management plan for delivery is
made for each patient; following birth mothers remain
under observation for at least 5 days. Post-discharge, they
attend a follow-up appointment with a member of the team
within 6 weeks.
However, even within established services such as the
Cuban Programme, care provided can differ from that
offered in high-income countries. A scarcity of resources
and expertise, as well as long travel distances to access
services and cultural, socioeconomic and ethnic differ-
ences in the populations served can all influence health-
care outcomes for the CHD patient. Hence, there is a
need to update and clarify the outcomes achieved for
these patients in these services; the following analysis
seeks to provide some such clarity.
Kinsella et al. Journal of Congenital Cardiology             (2019) 3:4 Page 2 of 7
Materials and methods
Study design and patient population
This was a retrospective single-centre study conducted
on a prospectively collected cardiac pregnancy database
at a tertiary referral hospital. The research protocol was
approved by the local Institutional Review Board. Verbal
informed consent was obtained for all participants in the
study; written informed consent was not deemed neces-
sary by the Review Board. The database comprised data
from 1st January 2000 to 15th May 2017, and included a
record of patients admitted under the Programme at its
base in the Hospital of Obstetrics and Gynaecology
“Ramon Gonzalez Coro” over this period. Data were
collected on discharge using both obstetric and medical
records, and anonymised at the point of collection,
hence it was not usually possible to identify patients
who presented to the Service in subsequent pregnancies.
Baseline data collected included: demographics (age,
province of origin), CHD diagnosis/diagnoses, presence
of significant co-morbidities, New York Heart Associ-
ation (NYHA) functional status class I-IV prior to preg-
nancy, and baseline ECG and echocardiography results.
Study outcomes and follow-up assessment
The primary data outcomes recorded were: duration of
pregnancy, outcome of pregnancy and any maternal or
fetal complications experienced. Additional labour out-
comes recorded included: mode of delivery, indication
for caesarean section, birthweight, gestational age at de-
livery, fetal gender and the use of oxytocin in induction
or augmentation of labour (data on the use of tocolytics
in the third stage of labour were not collected).
Small-for-gestational-age was defined as a baby born
with a birth weight less than the 10th centile. Intrauter-
ine growth restriction was defined as an estimated fetal
weight less than the 10th centile based on ultrasound
based centiles calculated using Hadlock’s formula. Ma-
ternal complications data were further classified into
cardiovascular and obstetric. Following delivery, further
maternal outcomes recorded included: post-partum
NYHA functional class, heart failure, resting oxygen
saturations (if abnormal: < 92%), arrhythmias requiring a
permanent pacemaker.
Results
A total of 501 cases were identified. Of these, 487 had
follow-up outcomes available at the time of analysis, and
so were included in the study. Of the 487 cases, 7 (1.4%)
were a repeat pregnancy, bringing the total number of
recorded pregnancies analysed to 495. Out of 495 preg-
nancies, 27 (5%) were terminated on or before 22 weeks
gestation, with one (0.2%) additional pregnancy termi-
nated at 26 weeks. Overall, 467 pregnancies were further
evaluated. Pregnancies from women who had more than
one pregnancy, were treated independently.
The baseline characteristics of the 467 CHD pregnan-
cies managed at the Hospital “Ramon Gonzalez Coro” are
described in Table 1. Overall, the median age at pregnancy
was 25 (21–29) years. While all Cuban provinces were
represented in the study population, most of the cases
originated from Havana (71%). Patients had a wide variety
of congenital heart defects (Table 1). Six cases involved a
mWHO IV classed cardiac lesion, where pregnancy is
contraindicated [18]. All cases presented in NYHA class I
(97%, n = 453) or II (3%, n = 14), 6% (n = 27) had arrhyth-
mias, 1% (n = 4) reported a significant co-morbidity, and
1% (n = 4) had impaired systemic ventricular function.
There were 464 singleton pregnancies and 3 twin
pregnancies (Table 2). Of the singleton pregnancies, one
pregnancy resulted in stillbirth (0.2%), with the rest
resulting in live births (99.8%, n = 463), at a median dur-
ation of gestation of 39.1 (38.6–40) weeks and a median
birth weight of 3200 (2900–3421) grams. Sixty-seven
percent of cases (n = 308) resulted in a vaginal delivery,
with caesarean section rates of 34% (n = 156). Oxytocin
was used in 98 (21%) deliveries before the third stage. In
77 deliveries (79%) this was for induction, and in 21
cases (21%) this was for augmentation. Indications for
caesarean delivery were divided into cardiovascular indi-
cations and obstetric indications. Cardiovascular indica-
tions existed in 19% of cases (n = 30). All six women
with mWHO class IV disease were delivered by caesar-
ean section: five were for cardiac reasons and one was
performed for obstetric reasons at 41 weeks gestation.
Only one of the five women with WHO Class IV disease
was delivered preterm (32 weeks gestation), and this was
for cardiac reasons. All twin pregnancies (n = 3) resulted
in live births (n = 6), at a median duration of gestation
of 37 (36–38) weeks, and a median birth weight of 2710
(2458–2850) grams. All twins were born via caesarean
section.
Maternal cardiovascular complications did not result
in mortality. One patient developed an arrhythmia, and
a further one severe mitral insufficiency. The most
prevalent maternal obstetric complication was gesta-
tional diabetes, which was present in 8% (n = 36) of
pregnancies. This was followed by gestational hyperten-
sion in 2% of pregnancies (n = 11), haemorrhage (1%,
n = 4), and uterine atony (1%, n = 4). Additionally, there
were reported cases of pre-eclampsia (< 0.5%, n = 2),
endometritis (< 0.5%, n = 2), sepsis (< 0.5%, n = 2), and
uterine rupture (< 0.5%, n = 1).
Within the cohort of live births, being
small-for-gestational-age was the commonest complica-
tion (10%, n = 48). Preterm birth affected 5% of pregnan-
cies (23 singleton, 1 twin), and intrauterine growth
restriction was noted in 3% of pregnancies (12
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singleton). Four women were delivered preterm due to
concerns about cardiac function (three at 32 completed
weeks and one at 34 completed weeks gestation), and all
four women were delivered by caesaraean section.
Following delivery, 4 singleton babies had a low Apgar
score (1%) (three at term and one preterm). Further
complications present in neonates included neonatal
jaundice (1%, 3 singleton babies), meconium aspiration
syndrome (< 0.5%, 1 singleton baby), hypoxia (< 0.5%, 1
singleton baby), and respiratory depression (< 0.5%, 1
singleton baby). Congenital malformations were found
in 5 singleton babies (1%). Three (1%) had congenital
cardiac defects (unrelated to the mother) and 2 (< 0.5%)
had other congenital malformations. Following birth and
up to 6 weeks of age, there were no reported neonatal
deaths.
Post-natal maternal cardiovascular outcomes are
summarised in Table 3. At 6 weeks follow-up, NYHA
functional status was class I in 84% (n = 393) of cases,
Table 1 Baseline characteristics
CHD pregnancies
(n = 467)
Age (years)a 25 (21–29)
Province of origin, n (%)
Pinar del Rio 12 (3)
Artemisa 28 (6)
Havana 330 (71)
Mayabeque 20 (4)
Matanzas 15 (3)
Cienfuegos 3 (1)
Villa Clara 2(< 0.5)
Sancti Spiritus 4 (1)
Ciego de Avila 7 (1)
Camaguey 8 (2)
Las Tunas 6 (1)
Granma 12 (3)
Holguin 7 (1)
Santiago de Cuba 3 (1)
Guantanamo 6 (1)
Isla de la Juventud 3 (1)
Other (Venezuela) 1 (< 0.5)
Diagnosis, n (%)
mWHO I 333 (71)
Atrial Septal Defect (ASD) - repaired 33 (7)
Atrial Septal Defect (ASD) - unrepaired 57 (12)
Atrioventricular Septal Defect (AVSD) - repaired 3 (1)
Atrioventricular Septal Defects (AVSD)
- unrepaired
3 (1)
Bicuspid aortic valve 5 (1)
Other 29 (6)
Patent Ductus Arteriosus (PDA) - repaired 7 (1)
Patent Ductus Arteriosus (PDA) - unrepaired 17 (4)
Pulmonary stenosis - repaired 11 (2)
Pulmonary stenosis (mild-moderate)
- unrepaired
52 (11)
Ventricular Septal Defect (VSD) - repaired 3 (1)
Ventricular Septal Defect (VSD) - unrepaired 113 (24)
mWHO II 81 (17)
Coarctation of the aorta - repaired 26 (6)
Coarctation of the aorta (mild-moderate)
- unrepaired
14 (3)
Tetralogy of Fallot - repaired 41 (9)
mWHO III 47 (10)
Aortic stenosis 2 (< 0.5)
Congenitally corrected Transposition of the
Great Arteries (cTGA)
2 (< 0.5)
Ebstein’s anomaly 14 (3)
Table 1 Baseline characteristics (Continued)
CHD pregnancies
(n = 467)
Fontan 3 (1)
Pulmonary regurgitation (mild – moderate)
- unrepaired
4 (1)
Pulmonary stenosis (severe) -unrepaired 5 (1)
Sub-aortic stenosis - repaired 3 (1)
Sub-aortic stenosis – unrepaired 9 (2)
Transposition of the Great Arteries (TGA)
– arterial switch
5 (1)
mWHO IV 6 (1)
Pulmonary Hypertension 4 (1)
Severe coarctation of the aorta
- unrepaired
2 (< 0.5)
Co-morbidities
Yes 4 (1)
No 463 (99)
Functional status at the start of pregnancy, n (%)
I 453 (97)
II 14 (3)
III 0 (0)
IV 0 (0)
Arrhythmias, n (%)
Yes 27 (6)
No 440 (94)
Left ventricular function, n (%)
Normal (> 55%) 463 (99)
Impaired (< 55%) 4 (1)
Baseline data collected on 467 CHD pregnancies managed by the Programme
2000–2017. aAge was only available for 463 patients. Continuous data is
presented as median (interquartile range)
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class II in nearly 16% (n = 73) and class III in a further
case (< 0.5%). Additionally, one patient (< 0.5%) developed
an arrhythmia requiring a permanent pacemaker and
another developed a severe mitral insufficiency (< 0.5%).
Discussion
Overall, the study identified 467 pregnancies (464 single-
ton, 3 twin). The median age at pregnancy in the study
population (25 years), is similar to that reported in stud-
ies of high-income countries (26–30 years) [4, 10, 23].
Some provinces in Cuba appear to be significantly
overrepresented (e.g. Havana) compared to others (e.g.
Santiago de Cuba), even when accounting for differences
in population density (see Fig. 1). To some extent this
can be explained by the dual function the Hospital
“Ramon Gonzalez Coro” plays as both the national refer-
ral centre for the management of high-risk CHD preg-
nancies, and also the regional centre for lower risk CHD
pregnancies. Nevertheless, the relatively low rate of cases
seen in some Cuban provinces compared to others (par-
ticularly to the capital) could indicate that patients
further afield are not being appropriately referred to the
programme, may be unwilling to travel to the capital for
monitoring, or are remaining undiagnosed and are
therefore not being referred.
Regarding pregnancy outcomes, the live birth rate
(99%) is particularly encouraging, with neonatal mortal-
ity rates approximately four times lower than have been
reported elsewhere for CHD pregnancies [10, 11]. How-
ever, it is important to note that the study population
was mixed in the level of risk the pregnancies presented;
a significant proportion of cases were classified as
low-risk. Overall, 89% of our cohort were in the mWHO
class I-II category, where pregnancy would be consid-
ered to pose either no risk or a small increased risk of
maternal mortality, or moderate increase in mortality
[10]; 97% of women in our cohort had a NHYA func-
tional score of I at the start of pregnancy. Whilst this
reflects the ACHD survivor population that would be
Table 2 Pregnancy outcomes
Singleton CHD
pregnancies (n = 464)
Twin CHD
pregnancies (n = 3)
Duration of pregnancy
(weeks)
39.1 (38.6–40.0) 37 (36–38)
Outcome of pregnancy
Live birth 463 (99) 6 (100)
Stillbirth 1 (< 1) 0 (0)
Live births (n = 463) Live births (n = 6)
Birth weight (gr) 3200 (2900–3421) a 2710 (2458–2850)
Mode of delivery, n (%)
Vaginal 308 (66) 0 (0)
Caesarean section 156 (34) 6 (100)
Indications for caesarean, n (%)
Cardiovascular indication 30 (19) 0 (0)
Obstetric indication 126 (81) 3 (100)
Maternal cardiovascular complications, n (%)
Mitral insufficiency 1 (< 0.5) 0 (0)
Arrhythmia 1 (< 0.5) 0 (0)
Maternal obstetric complications, n (%)
Gestational diabetes 35 (8) 1 (33)
Gestational hypertension 11 (2) 0 (0)
Pre-eclampsia 2 (< 0.5) 0 (0)
Thromboembolism 0 (0) 0 (0)
Haemorrhage 4 (1) 0 (0)
Haematoma 2 (< 0.5) 0 (0)
Endometritis 2 (< 0.5) 0 (0)
Uterine rupture 1 (< 0.5) 0 (0)
Uterine atony 3 (1) 1 (33)
Sepsis 2 (< 0.5) 0 (0)
Neonatal complications
Acute fetal distress 18 (4) 0 (0)
Preterm birth 22 (5) 2 (33)
Intrauterine growth
restriction
12 (3) 0 (0)
Small for gestational age 48 (10)a 0 (0)
Low Apgar score 4 (1) 0 (0)
Hypoxia 1 (< 0.5) 0 (0)
Respiratory depression 1 (< 0.5) 0 (0)
Meconium aspiration
syndrome
1 (< 0.5) 0 (0)
Neonatal jaundice 3 (1) 0 (0)
Congenital cardiac
defects
3 (1) 0 (0)
Other fetal malformations 2 (< 0.5) 0 (0)
Post-natal mortality 0 (0) 0 (0)
Pregnancy outcomes for 467 CHD pregnancies managed by the
Programme 2000–2017. aBirth weight and consequently small-for-
gestational-age results were only available for 462 neonates. Continuous
data is presented as median (interquartile range)
Table 3 Maternal cardiovascular outcomes at six-week follow-
up
CHD pregnancies
(n = 467)
Functional status, n (%)
I 393 (84)
II 73 (16)
III 1 (< 0.5)
IV 0 (0)
Arrhythmias requiring a permanent pacemaker,
n (%)
1 (< 0.5)
Severe mitral insufficiency 1 (< 0.5)
Follow-up maternal cardiovascular outcomes for 467 CHD pregnancies
managed by the Programme 2000–2017
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expected in a middle-income country, it also means live
birth outcomes may not be entirely comparable to stud-
ies with a greater focus on high-risk CHD pregnancies.
The caesarean rate reported for singleton pregnancies
(34%) is broadly similar to the rates reported in the lit-
erature [4], and lower than the national rate of caesarean
sections of 40% in Cuba [24]. The 19% rate of caesarean
section rate for cardiac indications may seem high given
that the majority of women were mWHOI and II, and
could be a reflection of clinician anxiety regarding
maternal wellbeing. In Cuba, a previous caesarean
section would be an indication for a further caesarean in
all subsequent pregnancies, differing from the practice
of most Western countries, where vaginal birth after
caesarean (VBAC) is now encouraged [25].
Rates of maternal cardiovascular complications are in
line with those reported by Drenthen et al [4], but lower
than most other studies [9, 11, 16]. Obstetric complica-
tions are generally lower than reported elsewhere [4],
though rates of gestational diabetes were higher than the
general Cuban population (8% vs 5.8% respectively) [26].
Lastly, neonatal adverse outcomes were also consistently
lower than reported by others [10, 11]. Rates of neonatal
CHD were relatively low [3].
At follow-up, maternal cardiac functional status had
decreased in 13% of the cohort. However, given the
short-follow up time post-delivery (6 weeks), one must
consider the context in which this outcome was mea-
sured; the decline in functional status could well be due
to non-cardiac reasons, e.g. the normal fatigue experi-
enced when looking after a new-born. It is therefore not
possible to establish the long-term effects pregnancy and
delivery have had on maternal cardiac function.
Strengths and limitations of the study
This work represents the largest report to date of a co-
hort of women, with 467 women with congenital cardiac
disease who embarked on pregnancy in Cuba. Moreover,
we have presented data from a middle-income health-
care system as few comparable reports exist in the litera-
ture [20–22]. However, owing to the study methodology,
it was not possible to reconcile patient data for patients
that had a subsequent pregnancy. As such, the analysis
was based on individual pregnancy cases managed by
the Service as opposed to outcomes based on inter-preg-
nancy dependent variables. The implications of this are
mainly that we have underestimated the deterioration in
cardiovascular function with subsequent pregnancies.
For example, a woman could have experienced a deteri-
oration in cardiovascular function in her 1st pregnancy,
which further decreased in a subsequent pregnancy.
However, given that most women had an NYHA score
of I at the start of pregnancy, this is unlikely to be the
case. Improvements in data linkage systems would en-
able more precise estimations of the impact of preg-
nancy on cardiovascular disease and vice versa. The
short follow-up time and retrospective nature of the
study also restrict the conclusions that can be made, par-
ticularly on long-term maternal cardiovascular outcomes
following pregnancy for CHD patients.
Conclusion
Pregnancy and labour can cause a significant burden to
the abnormal cardiovascular system. In the context of
CHD, appropriate risk-stratification measures and clear
management strategies developed within a multidiscip-
linary team remain critical for positive outcomes in both
Fig. 1 Regional map of Cuba, depicting the number of cases seen by the Service according to province
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mother and child. The results of this study serve to
demonstrate how, despite resource constraints, CHD pa-
tients can be successfully managed in middle-income
countries at similar levels to those in more high-income
healthcare systems. Nevertheless, the long-term outcomes
of pregnancy remain to be established, and present a
further avenue of research both in the developed and
developing world.
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